Portal Vein Occlusion is a Valuable Predictor for Postoperative Nausea and Vomiting
NCT ID: NCT05894408
Last Updated: 2024-04-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
380 participants
OBSERVATIONAL
2023-06-15
2023-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Risk Prediction Model of Postoperative Nausea and Vomiting in Patients With Liver Cancer
NCT06356623
External Validation of the Apfel Risk Score and Koivuranta Score to Predict Postoperative Nausea and Vomiting in Patients With Liver Cancer
NCT05014737
Evaluation of Portal Vein Stenting in Patients With Portal Vein Stenosis and Gastrointestinal Cancers
NCT04629677
A Clinical Study to Evaluate the Clinical Outcomes of Hepatectomy With Nutritional Risk After Preoperative Nutritional Support
NCT01292330
Effect of Goal-Oriented Albumin Infusion on Postoperative Complication Management in Gastric Cancer Surgery
NCT07119463
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Participants We calculated the sample size based on the rule-of-thumb method from logistic modelling as follows: a minimum of 10 events per predictor variable should be achieved based on simulation studies. The reported incidence of PONV among patients undergoing general surgery ranged from 30% to 50%. We used the lowest incidence of 30% to estimate the sample size. The expected variable number included in the logistic model was 9, and adjusting for a 10% of loss to follow-up, the sample size was 330.
Patients will be prospectively consecutively recruited. Patients who are diagnosed with liver cancer and underwent hepatectomy are eligible. Inclusion criteria are age older than 18 years, planned admissions and elective surgery, and staying at least 24 hours in the surgical unit. We exclude patients with cognitive impairment and patients who had nausea and vomiting related to other existing diseases, such as gastroesophageal reflux disease. We also exclude patients who have severe postoperative complications, including massive abdominal hemorrhage, hepatic encephalopathy and portal vein thrombosis.
3. Setting The study will be conducted in the liver disease department in Zhongshan Hospital, Shanghai, China, which is the largest liver surgery department in eastern China. In 2018, the department performs nearly 3000 liver surgeries. The liver surgical department has 240 beds, and the department staff includes 106 nurses and physicians.
4. Data collection 4.1 Preoperative assessment All enrolled patients will receive preoperative assessments by trained investigators. The baseline demographic data and medical history will be recorded. We define smoking history as nicotine use before surgery, and history of motion sickness as nausea or vomiting when travelling in a car/boat/train/plane. Nonsmoking and history of motion sickness or PONV will be collected by interviewing patients and family members.
4.2 Postoperative assessment All enrolled patients receive postoperative assessments by trained nurses. The use of postoperative opioids and the length of surgery are determined by checking the hospital information system to review surgery records and anaesthetic protocols within 24 hours after surgery. The time of portal vein occlusion will be recorded by the surgeon.
5. Surgery and postoperative management A standard general anaesthesia technique is used for all patients. Different operations are performed according to the preoperative conditions of each patient. S
6. Outcome measures Postoperative nausea and vomiting will be assessed hourly during the first two hours, every two hours for the following four hours and every four hours until the 24th hour by the first and the second authors to ensure high-quality data collection. PONV will be evaluated on a four-grade scale from 0 (no nausea and no vomiting), 1 (having nausea but no vomiting), 2 (having vomiting without stomach contents ) to 3 (having vomiting with stomach contents). A patient will be considered to have PONV if his or her PONV grade is 2 or more within the first 24 postoperative hours. PONV will be assessed by the first author, who is blinded to the result of portal vein occlusion.
7. Statistical analysis Statistical analyses are conducted using IBM-SPSS software version 22 (IBM Corp., Armonk, NY, USA), Empower (R) (www.empowerstats.com, X\&Y solutions, Inc., Boston, MA), and R statistical software. Data are presented as the mean and standard deviation for continuous variables and as percentages for categorical variables. Normally distributed continuous variables are compared using one-way analysis of variance. The Pearson χ2 test is applied to all categorical variables. Logistic regression models are used to investigate the effects of portal vein occlusion and the other variables on the occurrence of PONV in both univariate and multivariate analyses. Independent variables are selected based on evidence from previous studies showing a significant relation to PONV and we also include other variables based on our clinical experience.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
patients with portal vein occlusion
this is no intervention
this is no intervention
patients without portal vein occlusion
this is no intervention
this is no intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
this is no intervention
this is no intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shanghai Zhongshan Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fudan University Fudan University
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Chen X, Zhao WJ, Yu J, Zhou H, Shi Y, Gao J, Zhang Y. Duration of hepatic portal occlusion is a valuable predictor for postoperative nausea and vomiting in patients underwent liver resection for liver cancer. BMC Cancer. 2025 Jul 16;25(1):1177. doi: 10.1186/s12885-025-14592-0.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SHDC22020204
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.